Dhatariya, K. K., Parsekar, K., Skedgel, C. ORCID: https://orcid.org/0000-0003-4989-8846, Datta, V., Hill, P. and Fordham, R.
ORCID: https://orcid.org/0000-0002-5520-6255
(2019)
The cost of treating diabetic ketoacidosis in an adolescent population in the UK: a national survey of hospital resource use.
Diabetic Medicine, 36 (8).
pp. 982-987.
ISSN 0742-3071
Preview |
PDF (Accepted_Manuscript)
- Accepted Version
Download (777kB) | Preview |
Abstract
Aims: Adolescents with Type 1 diabetes commonly experience episodes of ketoacidosis. In 2014, we conducted a nationwide survey on the management of diabetic ketoacidosis in young people. The survey reported how individual adolescents with diabetes were managed. However, the costs of treating diabetic ketoacidosis were not reported. Methods: Using this mixed population sample of adolescents, we took a ‘bottom-up’ approach to cost analysis aiming to determine the total expense associated with treating diabetic ketoacidosis. The data were derived using the information from the national UK survey of 71 individuals, collected via questionnaires sent to specialist paediatric diabetes services in England and Wales. Results: Several assumptions had to be made when analysing the data because the initial survey collection tool was not designed with a health economic model in mind. The mean time to resolution of diabetic ketoacidosis was 15.0 h [95% confidence interval (CI) 13.2, 16.8] and the mean total length of stay was 2.4 days (95% CI 1.9, 3.0). Based on data for individuals and using the British Society of Paediatric Endocrinology and Diabetes (BSPED) guidelines, the cost analysis shows that for this cohort, the average cost for an episode of diabetic ketoacidosis was £1387 (95% CI 1120, 1653). Regression analysis showed a significant cost saving of £762 (95% CI 140, 1574; P = 0.04) among those treated using BSPED guidelines. Conclusion: We have used a bottom-up approach to calculate the costs of an episode of diabetic ketoacidosis in adolescents. These data suggest that following treatment guidelines can significantly lower the costs for managing episodes of diabetic ketoacidosis.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | internal medicine,endocrinology, diabetes and metabolism,endocrinology,sdg 3 - good health and well-being ,/dk/atira/pure/subjectarea/asjc/2700/2724 |
Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
UEA Research Groups: | Faculty of Medicine and Health Sciences > Research Groups > Health Economics Faculty of Medicine and Health Sciences > Research Groups > Public Health and Health Services Research (former - to 2023) |
Related URLs: | |
Depositing User: | LivePure Connector |
Date Deposited: | 08 Feb 2019 11:31 |
Last Modified: | 21 Oct 2022 21:37 |
URI: | https://ueaeprints.uea.ac.uk/id/eprint/69892 |
DOI: | 10.1111/dme.13893 |
Downloads
Downloads per month over past year
Actions (login required)
![]() |
View Item |